U-M Division of GI & Hepatology Researchers

The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis, and treatment of gastrointestinal diseases.

Dr. Robert Fontana discusses his study that has global impact on Hepatitis C elimination efforts.

In our mission to create knowledge through research, the Division of Gastroenterology and Hepatology continues to conduct cutting-edge investigations of the molecular, cellular, and physiological conditions of healthy and diseased states of the gastrointestinal tract, liver, and pancreas. The central piece of the Division's research endeavor is the NIH-funded University of Michigan Center for Gastrointestinal Research, which encompasses three thematic areas of research:

  1. neurobiology of appetite control and visceral pain
  2. molecular and cellular mechanisms of inflammation
  3. cell growth, differentiation, and programmed cell death

Research Highlights

Racial and Ethnic Disparities Exist in Prescribing Rifaximin for Patients with Hepatic Encephalopathy

Elliot Tapper, MD; Neehar Parikh, MD, MS; and team find that Black Americans experience significant health inequities when receiving treatment for this cirrhosis-related disorder.

Fighting COVID-19 with Milk?

Jonathan Sexton, PhD and team investigate the antiviral properties of cow milk protein against variants of SARS-CoV-2.

Consider Individualized Approach for Systemic Therapy in HCC

Grace Su, MD leads team in updating the AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma.